Astria Therapeutics Inc (ATXS)
9.695
+0.14
(+1.52%)
USD |
NASDAQ |
May 06, 14:42
Astria Therapeutics Max Drawdown (5Y): 98.65% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.65% |
March 31, 2024 | 98.65% |
February 29, 2024 | 98.65% |
January 31, 2024 | 98.65% |
December 31, 2023 | 98.65% |
November 30, 2023 | 98.65% |
October 31, 2023 | 98.65% |
September 30, 2023 | 98.65% |
August 31, 2023 | 98.65% |
July 31, 2023 | 98.65% |
June 30, 2023 | 98.65% |
May 31, 2023 | 98.65% |
April 30, 2023 | 98.65% |
March 31, 2023 | 98.65% |
February 28, 2023 | 98.65% |
January 31, 2023 | 98.65% |
December 31, 2022 | 98.65% |
November 30, 2022 | 98.65% |
October 31, 2022 | 98.65% |
September 30, 2022 | 98.65% |
August 31, 2022 | 98.65% |
July 31, 2022 | 98.65% |
June 30, 2022 | 98.65% |
May 31, 2022 | 98.38% |
April 30, 2022 | 98.38% |
Date | Value |
---|---|
March 31, 2022 | 98.38% |
February 28, 2022 | 98.38% |
January 31, 2022 | 98.38% |
December 31, 2021 | 98.38% |
November 30, 2021 | 98.38% |
October 31, 2021 | 98.38% |
September 30, 2021 | 98.38% |
August 31, 2021 | 98.38% |
July 31, 2021 | 98.38% |
June 30, 2021 | 98.38% |
May 31, 2021 | 98.38% |
April 30, 2021 | 98.38% |
March 31, 2021 | 98.38% |
February 28, 2021 | 98.38% |
January 31, 2021 | 98.38% |
December 31, 2020 | 98.38% |
November 30, 2020 | 98.38% |
October 31, 2020 | 98.35% |
September 30, 2020 | 98.09% |
August 31, 2020 | 98.09% |
July 31, 2020 | 98.09% |
June 30, 2020 | 98.09% |
May 31, 2020 | 98.09% |
April 30, 2020 | 98.09% |
March 31, 2020 | 98.09% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.26%
Minimum
May 2019
98.65%
Maximum
Jun 2022
98.26%
Average
98.38%
Median
Nov 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -38.34 |
Beta (5Y) | 0.811 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.2% |
Historical Sharpe Ratio (5Y) | -0.276 |
Historical Sortino (5Y) | -0.5423 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.29% |